ASCO GU 2021 – Rare Tumors

March 15, 2021

Cabozantinib and nivolumab present clinical activity in the treatment of metastatic genitourinary tumors

Cabozantinib associated with nivolumab, as well as the combination of cabozantinib plus nivolumab and ipilimumab, showed promising efficacy and safety in a dose-escalation phase I trial in patients […]
February 23, 2021

Precision medicine: genomic profile differences between penile and male urethral SCC

Although squamous cell carcinoma of the penis (pSCC) and male urethral epithelium (uSCC) appear in nearby localizations and may have similar histology, its clinical manifestations, disease […]